← Leaderboards
Satoshi Kashiwagi
Massachusetts General Hospital
$2,337,652
Attributed
$2,803,831
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $699.3K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,803,831 · 3
By mechanism
R01$2,370,392 · 2
R21$433,439 · 1
Top collaborators
- Michael Bouvet1 shared
- Maged M Henary1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Harald W. Jueppner$19,159,604
- Murat Bastepe$9,215,842
- Hak Soo Choi$7,452,919
- Maged M Henary$3,266,074
- Mei X Wu$13,491,815
Others in their field
Top investigators on “Light”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- David H Reitze · University Of Florida$147,527,083
- Albert Lazzarini · California Institute Of Technology$147,193,333
Research focus
LightMediatingTechnologySafetyDoseSkinAdjuvantResponseAntigensBaseAuthorityMolecularClinically RelevantVaccinesImmune ResponseLasersKeratinocyteMedicalMast CellCellsAnimal ModelAreaAdverse EffectsAbsorption
Grant awards (7)
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$699,269
R01 · FY2025 · CA · contact PI
Laser-based non-invasive immunotherapy for food allergy$200,479
R21 · FY2020 · AI · contact PI
Laser-based non-invasive immunotherapy for food allergy$232,960
R21 · FY2019 · AI · contact PI
Near-infrared laser to replace chemical vaccine adjuvant$424,143
R01 · FY2016 · AI · contact PI
Near-infrared laser to replace chemical vaccine adjuvant$424,143
R01 · FY2015 · AI · contact PI
Near-infrared laser to replace chemical vaccine adjuvant$424,143
R01 · FY2014 · AI · contact PI
Near-infrared laser to replace chemical vaccine adjuvant$398,694
R01 · FY2013 · AI · contact PI